201 related articles for article (PubMed ID: 21729304)
41. VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement.
Drela E; Kulwas A; Jundziłł W; Góralczyk B; Boinska J; Drewniak W; Gadomska G; Rość D
Endokrynol Pol; 2014; 65(4):306-12. PubMed ID: 25185854
[TBL] [Abstract][Full Text] [Related]
42. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
43. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.
Brogi E; Wu T; Namiki A; Isner JM
Circulation; 1994 Aug; 90(2):649-52. PubMed ID: 8044933
[TBL] [Abstract][Full Text] [Related]
44. Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.
Kahlert C; Fiala M; Musso G; Halama N; Keim S; Mazzone M; Lasitschka F; Pecqueux M; Klupp F; Schmidt T; Rahbari N; Schölch S; Pilarsky C; Ulrich A; Schneider M; Weitz J; Koch M
Oncotarget; 2014 Dec; 5(24):12978-89. PubMed ID: 25483099
[TBL] [Abstract][Full Text] [Related]
45. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
46. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
[TBL] [Abstract][Full Text] [Related]
47. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
[TBL] [Abstract][Full Text] [Related]
48. Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.
Sabbaghian MS; Rothberger G; Alongi AP; Gagner JP; Goldberg JD; Rolnitzky L; Chiriboga L; Hajdu CH; Zagzag D; Basch R; Shamamian P
Anticancer Res; 2010 Jul; 30(7):2911-7. PubMed ID: 20683032
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
50. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
[TBL] [Abstract][Full Text] [Related]
51. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
53. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
[TBL] [Abstract][Full Text] [Related]
54. Serum JAK/STAT profile is related to the IL expression but not with the outcome in pancreatic adenocarcinoma patients.
Petrusel L; Ilies M; Leucuta D; Rusu I; Seicean A; Iuga C; Seicean R
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):107-112. PubMed ID: 34933726
[TBL] [Abstract][Full Text] [Related]
55. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
56. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
Kruger D; Yako YY; Devar J; Lahoud N; Smith M
PLoS One; 2019; 14(8):e0221169. PubMed ID: 31415645
[TBL] [Abstract][Full Text] [Related]
57. Traumatic spinal cord injury alters angiogenic factors and TGF-beta1 that may affect vascular recovery.
Ritz MF; Graumann U; Gutierrez B; Hausmann O
Curr Neurovasc Res; 2010 Nov; 7(4):301-10. PubMed ID: 20860549
[TBL] [Abstract][Full Text] [Related]
58. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
[TBL] [Abstract][Full Text] [Related]
59. Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis.
Ziora D; Jastrzębski D; Adamek M; Czuba Z; Kozielski JJ; Grzanka A; Kasperska-Zajac A
BMC Pulm Med; 2015 Oct; 15():113. PubMed ID: 26438257
[TBL] [Abstract][Full Text] [Related]
60. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
